Medilink UK Announce New Chair – Sir Andrew Cash

With more than 35 years of senior leadership experience, Sir Andrew Cash OBE GCStJ has made a significant contribution to advancing healthcare delivery through innovation and partnership working at local, regional and national level. His roles have included Chair and Chief Executive of NHS Trusts, Chair of NHS Employers, Vice Chair of the NHS Confederation, Chair of an Integrated Care Board and Chair of the Board of Trustees of the St John of Jerusalem Eye Hospital Group.

 

Sir Andrew joined the UK’s National Health Service (NHS) as a fast-track graduate trainee and became the CEO of the Sheffield Teaching Hospitals NHS Foundation Trust from 2004 to 2018. His experience as a Chair, CEO and Non-Executive Director spans health, life science, charity and consultancy services. 

 Commenting on the appointment, Kevin Kiely MBE, Group Chief Executive, Medilink UK said, “The Medilink UK Board were absolutely delighted that someone of Sir Andrew’s considerable experience across the health and life science sector, agreed to become Medilink UK Chair. The need for the NHS, the life science industry and academia to collaborate to transform healthcare delivery and boost economic growth has never been greater, and we look forward to Sir Andrew’s support going forward.”

 Sir Andrew replied, “I have watched Medilink develop from a regional initiative over 30 years ago, to a nationally recognised professional association which brings together innovative companies, NHS Trusts and universities in regions across the UK, to drive much needed innovation, not only in the NHS but through its considerable international connectivity, in healthcare delivery systems across the world. I value this opportunity to contribute to the valuable work of Medilink UK”.

 Medilink UK is the largest representative body in the UK for life sciences, a network of not-for-profit regional organisations dedicated to improving healthcare across the country, with a strong track record in increasing the viability of manufacturers, service providers, designers, OEMs and suppliers of medical technology, pharmaceuticals, and biotechnology products.

Additionally, their expert and experienced Medilink UK team provide a range of specialist services to support the life sciences community in the UK.

 For more information on Medilink UK, visit www.medilinkuk.com

Julie Maggs